News

In collaboration with colleagues at the Walter and Eliza Hall Institute (WEHI) and the University of Melbourne, Hudson Institute scientists have revealed how inflammation in motor neuron disease (MND) is caused,…  Read more

It is unknown how US President Donald Trump will respond to the experimental immunotherapy given to treat his COVID-19 infection, because the drug has not yet been tested and approved, says Hudson Institute Director and CEO, Professor Elizabeth Hartland.…  Read more

Hudson Institute scientists have discovered the key to how cells turn on inflammation and fight infection, providing the knowledge to potentially reduce or stop destructive inflammation in the future.…  Read more

Australia’s medical research sector will benefit from the appointment of Hudson Institute inflammation scientist Associate Professor Ashley Mansell to global firm Morningside BioPharma Advisory,…  Read more

Inflammation is at the core of life-threatening severe COVID-19 cases. More than 100 researchers at Hudson Institute investigate…  Read more

Hudson Institute has received Victorian Government recognition under a workplace program encouraging healthy lifestyles.…  Read more

The first clinical trial of a potential COVID-19 treatment involving a discovery by Hudson Institute researchers received approval in September.…  Read more

A new Chair in Neonatal Paediatrics will fast-track Monash University, Monash Health and Hudson Institute’s joint vision for newborn medicine and serve the community through advanced treatments…  Read more

Congratulations to Dr Marius Dannappel and Dr Madara Ratnadiwakara who have been awarded The Ron Evans AM Fellowship to progress treatments for bowel cancer.…  Read more

Ten Hudson Institute PhD students have been selected for the first time to participate in the high-level mentoring program, Industry Mentoring Network in STEM (IMNIS).…  Read more